CHIMERIX INC. - COMMO
0.9351
07-十一月-24 15:59:42
15 分钟延时
股票
-0.0749
-7.42%
今日范围
0.9079 - 1.0500
ISIN
N/A
来源
NASDAQ
-
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
28 2月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
23 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
05 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
08 12月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
Chimerix Responds to Rubric Capital Management
10 11月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
03 11月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
27 10月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
26 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
29 8月 2022 10:45:00 条件 Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update
08 8月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Chimerix to Present at Wedbush PacGrow Healthcare Conference
02 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
01 8月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
24 6月 2022 10:06:16 条件 Nasdaq GlobeNewswire
-
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23 6月 2022 09:15:16 条件 Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies Global Healthcare Conference
01 6月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright Global Investment Conference
17 5月 2022 16:15:00 条件 Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
16 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
16 5月 2022 06:30:00 条件 Nasdaq GlobeNewswire